
Difozin 5mg Tablet
Marketer
Lincoln Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Difozin 5mg Tablet
Glimepiride 5mg tablets are indicated for managing type 2 diabetes, either independently or in conjunction with other medications. They effectively regulate elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. This medication may be administered with or without food, consistently at the same time each day, as determined by your physician. Discontinuation should only occur under medical supervision; abrupt cessation can lead to hyperglycemia and potentially serious consequences such as renal impairment or vision loss. This treatment forms part of a comprehensive program encompassing a balanced diet, regular physical activity, and weight management, as advised by your doctor. Common adverse effects include vaginal yeast infections, upper respiratory infections, and urinary tract infections; dehydration is also possible, necessitating increased fluid intake. Practicing good hygiene can help prevent genital infections. Prior to commencing treatment, disclose any existing kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should consult their physician before use. Limit alcohol consumption during treatment to minimize potential side effects. Regular blood glucose monitoring is essential while using this medication.
Primary Ingredients of Difozin 5mg Tablet
There is no text provided to rephrase.
Uses of Difozin 5mg Tablet
Managing type 2 diabetes
Major Benefits of Difozin 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Difozin 5mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Difozin 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Difozin 5mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Difozin 5mg tablets can be administered with or without food, though consistent timing is recommended.
How Difozin 5mg Tablet works:
Glycemia control is achieved with Difozin 5mg tablets, an antidiabetic agent that facilitates urinary excretion of surplus glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Difozin 5mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Difozin 5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Difozin 5mg tablets are likely incompatible. Available data from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Difozin 5mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Difozin 5mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Difozin 5mg Tablet :
Should you forget a Difozin 5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Difozin 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
